Nearly two months after the FDA nixed its hemophilia gene therapy, BioMarin has a new…
eabramovichOctober 6, 2020
The first thing James Monaghan, an associate professor of biology at Northeastern, does on a normal…
eabramovichOctober 6, 2020
Cancer therapies that target specific molecular defects arising from mutations in tumor cells are currently…
eabramovichOctober 5, 2020
Alnylam Pharmaceuticals set the stage for another drug approval after reporting Wednesday that it successfully…
eabramovichOctober 2, 2020
Under a microscope, the first few hours of every multicellular organism’s life seem incongruously chaotic.…
eabramovichOctober 2, 2020
UMass Medical School researchers have been awarded a $3.3 million, four-year National Institute on Aging…
eabramovichOctober 1, 2020
Waters says the need to accelerate collaborative research wrought by the COVID-19 pandemic has prompted…
eabramovichOctober 1, 2020
Neuropsychiatric illnesses like schizophrenia and autism are a complex interplay of brain chemicals, environment, and…
eabramovichOctober 1, 2020
For a long time, pain and inflammation were thought to be two separate biological responses.…
eabramovichSeptember 30, 2020
